![]() Starting from the preliminary animal studies of the late 1980s, the evolution of our understanding of hypoglossal nerve stimulation culminated in the development of the Inspire II (Inspire Medical Systems, Inc Maple Grove, Minnesota), the first, and currently only, US Food and Drug Administration (FDA)-approved implantable hypoglossal nerve stimulation system to treat OSA. Supported Monday to Friday 8am–6pm (excluding bank holidays and university closure days).Reflecting the scientific advances of the past several decades, hypoglossal nerve stimulation has emerged as an important tool for the treatment of obstructive sleep apnea (OSA). There is no cost to the user for this service Availability The Software must be requested by contacting IT Services Cost
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |